Cancer
Malignant Bladder Neoplasm
CI-CAN-00005866Explore in graph →
Top-level346 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005866Explore in graph →
Clinical trials
1,510 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07474519 | Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer | recruiting | Phase 4 | 40 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT03348969 | Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC(NICSA) | completed | Phase 4 | 120 | Jørgen Bjerggaard JensenOTHER |
| 1 |
| Mar 3, 2026 |
| clinicaltrials |
| NCT06764095 | Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial | recruiting | Phase 4 | 75 | Mayo ClinicOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT05962541 | Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)(CUT-less) | recruiting | Phase 4 | 327 | University of Roma La SapienzaOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT04502095 | Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy | completed | Phase 4 | 89 | Roswell Park Cancer InstituteOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT04532606 | Impact of Remimazolam on Prognosis After Bladder Cancer Surgery | recruiting | Phase 4 | 1,128 | Peking University First HospitalOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT06390111 | A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose.(ABLE-42) | withdrawn | Phase 4 | 0 | Ferring PharmaceuticalsINDUSTRY | 1 | Nov 22, 2024 | clinicaltrials |
| NCT06215976 | The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer | unknown | Phase 4 | 78 | Cairo UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT06548438 | The Impact of PDD During TURB for NMIBC(TUR_BLUE) | not yet recruiting | Phase 4 | 300 | A.O.U. Città della Salute e della ScienzaOTHER | 0 | Aug 12, 2024 | clinicaltrials |
| NCT05488353 | A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma | unknown | Phase 4 | 48 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Aug 4, 2022 | clinicaltrials |
| NCT05220124 | A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma | unknown | Phase 4 | 190 | Tianjin Medical University Second HospitalOTHER | 1 | Feb 2, 2022 | clinicaltrials |
| NCT03063255 | Comparison of Obturator Nerve Blockade and Neuromuscular Blockade | completed | Phase 4 | 60 | University of FloridaOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT03138967 | Investigation of Sugammadex in Outpatient Urological Procedures | completed | Phase 4 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 22, 2020 | clinicaltrials |
| NCT03147599 | Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders | completed | Phase 4 | 110 | Mansoura UniversityOTHER | 1 | Jun 30, 2020 | clinicaltrials |
| NCT03831321 | The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy | unknown | Phase 4 | 144 | Taha UçarOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT03790384 | Sequential Combination Therapy in Bladder Cancer(MITOBCG) | unknown | Phase 4 | 140 | Azienda Ospedaliera "Sant'Andrea"OTHER | 0 | Dec 31, 2018 | clinicaltrials |
| NCT02214602 | Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer(NMIBCIVT) | completed | Phase 4 | 240 | Mansoura UniversityOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT00666978 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | completed | Phase 4 | 540 | Lisa Sanderson Cox, PhDOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT03274284 | Chemoradiotherapy for Recurrent T1G3 Bladder Cancer | unknown | Phase 4 | 20 | Assiut UniversityOTHER | 0 | Sep 11, 2017 | clinicaltrials |
| NCT03174912 | In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? | completed | Phase 4 | 400 | Ankara Training and Research HospitalOTHER | 0 | Jun 5, 2017 | clinicaltrials |
| NCT03038321 | Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? | unknown | Phase 4 | 150 | Mansoura UniversityOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT03147586 | Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy | unknown | Phase 4 | 100 | Mansoura UniversityOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT00365508 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | completed | Phase 4 | 642 | Fox Chase Cancer CenterOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT02443844 | Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression | unknown | Phase 4 | 40 | Diskapi Teaching and Research HospitalOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT00785694 | Recurrence of Bladder Cancer After Transurethral Resection With Hexvix | withdrawn | Phase 4 | 0 | GE HealthcareINDUSTRY | 1 | Apr 24, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Mar 16, 2026source: clinicaltrials